Outcomes4Me – a developer of the leading direct-to-patient and AI-based platform transforming the cancer care experience – announced the closing of a $21 million funding round. With this round, Outcomes4Me welcomes a new investor, London-based Salica Investments, alongside all existing investors: Labcorp Venture Fund, Forecast Labs, Northpond Ventures, Sierra Ventures, Asset Management Ventures, IRA Capital, and Merstal LTD. This brings Outcomes4Me’s total capital raised to date to $38 million.